Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.

Scheen AJ, Charpentier G, Ostgren CJ, Hellqvist A, Gause-Nilsson I.

Diabetes Metab Res Rev. 2010 Oct;26(7):540-9. doi: 10.1002/dmrr.1114.

PMID:
20824678
[PubMed - indexed for MEDLINE]
2.

Sitagliptin/metformin fixed-dose combination: in patients with type 2 diabetes mellitus.

Chwieduk CM.

Drugs. 2011 Feb 12;71(3):349-61. doi: 10.2165/11206060-000000000-00000. Review.

PMID:
21319871
[PubMed - indexed for MEDLINE]
3.

Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events.

Ahrén B.

Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):487-98. doi: 10.1016/j.beem.2009.03.003. Review.

PMID:
19748066
[PubMed - indexed for MEDLINE]
4.

Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus.

Neumiller JJ, Campbell RK.

Am J Health Syst Pharm. 2010 Sep 15;67(18):1515-25. doi: 10.2146/ajhp090555. Review.

PMID:
20811029
[PubMed - indexed for MEDLINE]
5.

Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetes.

Mikhail N.

Expert Opin Investig Drugs. 2008 Jun;17(6):845-53. doi: 10.1517/13543784.17.6.845 . Review.

PMID:
18491986
[PubMed - indexed for MEDLINE]
6.

Saxagliptin: a review of its use as combination therapy in the management of type 2 diabetes mellitus in the EU.

Yang LP.

Drugs. 2012 Jan 22;72(2):229-48. doi: 10.2165/11208160-000000000-00000. Review.

PMID:
22221000
[PubMed - indexed for MEDLINE]
7.

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis.

Gerrald KR, Van Scoyoc E, Wines RC, Runge T, Jonas DE.

Diabetes Obes Metab. 2012 Jun;14(6):481-92. doi: 10.1111/j.1463-1326.2011.01540.x. Epub 2011 Dec 27. Review.

PMID:
22098472
[PubMed - indexed for MEDLINE]
8.

DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.

Scheen AJ.

Diabetes Metab. 2012 Apr;38(2):89-101. doi: 10.1016/j.diabet.2011.11.001. Epub 2011 Dec 22. Review.

PMID:
22197148
[PubMed - indexed for MEDLINE]
Free Article
9.

Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes.

Lam S, Saad M.

Cardiol Rev. 2010 Jul-Aug;18(4):213-7. doi: 10.1097/CRD.0b013e3181daad5f. Review.

PMID:
20539105
[PubMed - indexed for MEDLINE]
10.

Reaching HbA1c goals with saxagliptin in combination with other oral antidiabetic drugs.

LaSalle JR.

Postgrad Med. 2010 Jan;122(1):144-52. doi: 10.3810/pgm.2010.01.2108. Review.

PMID:
20107298
[PubMed - indexed for MEDLINE]
11.

Vildagliptin: a review of its use in type 2 diabetes mellitus.

Keating GM.

Drugs. 2010 Nov 12;70(16):2089-112. doi: 10.2165/11206370-000000000-00000. Review.

PMID:
20964454
[PubMed - indexed for MEDLINE]
12.
13.

Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.

Tahrani AA, Piya MK, Barnett AH.

Adv Ther. 2009 Mar;26(3):249-62. doi: 10.1007/s12325-009-0014-9. Epub 2009 Mar 27. Review. Erratum in: Adv Ther. 2009 Jul;26(7):736.

PMID:
19330494
[PubMed - indexed for MEDLINE]
14.

Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.

Scheen AJ.

Diabetes Obes Metab. 2010 Aug;12(8):648-58. doi: 10.1111/j.1463-1326.2010.01212.x. Review.

PMID:
20590741
[PubMed - indexed for MEDLINE]
15.

Saxagliptin: a clinical review in the treatment of type 2 diabetes mellitus.

Kania DS, Gonzalvo JD, Weber ZA.

Clin Ther. 2011 Aug;33(8):1005-22. doi: 10.1016/j.clinthera.2011.06.016. Epub 2011 Jul 28. Review.

PMID:
21802144
[PubMed - indexed for MEDLINE]
16.

New combination treatments in the management of diabetes: focus on sitagliptin-metformin.

Green J, Feinglos M.

Vasc Health Risk Manag. 2008;4(4):743-51. Review.

PMID:
19065992
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

Schwartz SL.

Ann Med. 2012 Mar;44(2):157-69. doi: 10.3109/07853890.2011.603701. Epub 2011 Dec 1. Review.

PMID:
22132773
[PubMed - indexed for MEDLINE]
18.

Sitagliptin: a novel drug for the treatment of type 2 diabetes.

Choy M, Lam S.

Cardiol Rev. 2007 Sep-Oct;15(5):264-71. Review.

PMID:
17700385
[PubMed - indexed for MEDLINE]
19.

Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.

Scheen AJ.

Expert Opin Drug Metab Toxicol. 2012 Mar;8(3):383-94. doi: 10.1517/17425255.2012.658771. Epub 2012 Feb 8. Review.

PMID:
22313172
[PubMed - indexed for MEDLINE]
20.

Sitagliptin in clinical practice: a new approach in the treatment of type 2 diabetes.

Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS.

Expert Opin Pharmacother. 2008 Jul;9(10):1705-20. doi: 10.1517/14656566.9.10.1705 . Review.

PMID:
18570604
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk